Having polycystic ovary syndrome may make the following conditions more likely, especially if obesity also is a factor:
Sept. 03, 2014
- Type 2 diabetes
- High blood pressure
- Cholesterol and lipid abnormalities, such as elevated triglycerides or low high-density lipoprotein (HDL) cholesterol, the "good" cholesterol
- Metabolic syndrome — a cluster of signs and symptoms that indicate a significantly increased risk of cardiovascular disease
- Nonalcoholic steatohepatitis — a severe liver inflammation caused by fat accumulation in the liver
- Sleep apnea
- Depression and anxiety
- Abnormal uterine bleeding
- Cancer of the uterine lining (endometrial cancer), caused by exposure to continuous high levels of estrogen
- Gestational diabetes or pregnancy-induced high blood pressure
- Hoffman BL, et al. Williams Gynecology. 2nd ed. New York, N.Y.: The McGraw-Hill Companies; 2012. http://accessmedicine.com/resourceTOC.aspx?resourceID=768. Accessed June 2, 2014.
- Barbieri RL, et al. Clinical manifestations of polycystic ovary syndrome in adults. http://www.uptodate.com/home. Accessed June 4, 2014.
- Barbieri RL, et al. Treatment of polycystic ovary syndrome in adults. http://www.uptodate.com/home. Accessed June 4, 2014.
- AskMayoExpert. What is the initial therapy recommended for polycystic ovary syndrome (PCOS)? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Polycystic ovary syndrome (PCOS) fact sheet. Womenshealth.gov. http://www.womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html. Accessed June 4, 2014.
- Sirmans SM, et al. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology. 2014;6:1.
- Legro RS, et al. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 2013;98:4565.
- Strauss JF, et al. Yen & Jaffe's Reproductive Endocrinology. 7th ed. Philadelphia, Pa. Elsevier Saunders; 2014. http://www.clinicalkey.com. Accessed June 11, 2014.
- Gonzalez F. Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77:300.
- Golden AK. Decision Support System. Mayo Clinic, Rochester, Minn. April 25, 2014.
- Coddington CC (expert opinion). Mayo Clinic, Rochester, Minn. July 6, 2014.
- Domecq JP, et al. Lifestyle modification programs in polycystic ovary syndrome: Systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism. 2013;98:4655.